medigraphic.com

2014, Número 3

<< Anterior Siguiente >>

Rev Hematol Mex 2014; 15 (3)


Diferencias clínicas de la trombocitopenia inmunitaria entre los niños y los adultos: posible explicación patogénica

Ron-Guerrero CS

Idioma: Español
Referencias bibliográficas: 19
Paginas: 142-147
Archivo PDF: 523.48 Kb.


RESUMEN

La trombocitopenia inmunitaria primaria se conoce desde hace más de un siglo; sin embargo, los mecanismos fisiopatológicos apenas empiezan a aclararse. Las células T reguladoras en las enfermedades inmunitarias tienen un papel fisiopatológico central en la trombocitopenia inmunitaria. Aunque el desajuste inmunológico es el común denominador en los niños y en los adultos, existen diferencias clínicas que aún no se han explicado. El propósito de este artículo es externar mi opinión de por qué al ser la misma enfermedad, en los niños es más favorable que en los adultos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Harrington WJ, Minnich V, Hollingsworth JW, Moore CV, Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951;38:1-10.

  2. Kühne T. History of the pathogenesis of ITP. En: Kühne T, editor. Immune thrombocytopenia (PTI). 2nd ed. London, Boston: UNI-MED Verlag AG, 2013;20.

  3. McMillian R. The pathogenesis of chronic immune (idiopathic) thrombocytopenia. Sem Hematol 2000;37:5-9.

  4. Semple JW, Milev Y, Cosgrave D, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: Relationship to platelet phenotype and antiplatelet T-Cell reactivity. Blood 1996;87:4245-4254.

  5. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009;113:2386-2393.

  6. Semple JW. T cell and cytokine abnormalities in patients with autoimmune thrombocytopenic purpura. Transfus Apher Sci 2003;28:237-242.

  7. Anderson PO, Stockelberg D, Jacobsson S, Wadenvik H. Transforming growth factor β1-mediated by stander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann Haematol 2000;79:507-513.

  8. Mosmann TR, Coffman RL. Th1y Th2 cells: different patters of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.

  9. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164.

  10. Sakakura M, Wada H, Tawara I, et al. Reduced CD4+ CD25+ Tcells in patient with idiopathic thrombocytopenic purpura. Thromb Res 2007;120:187-193.

  11. Li N, Mou W, Lu G, et al. Low-dose rituximab combined with short-term glucocorticoid up-regulates Tregs cell levels in patients with immune thrombocytopenia. In J Hematol 2011;93:91-98.

  12. Van Leeuwen EF, van der Ven TJ, Engelfriet CP, von dem Borne AE. Specifity of autoantiobodies in autoimmune thrombocytopenia. Blood 1982;59:23-26.

  13. He R, Reid MD, Jones CE, Shulman NR. Spectroum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood 1994;83:1024-1032.

  14. Van der Harst D, de Jong D, Limpens J, et al. Clonal B cell populations in patients with idiopathic thrombocytopenic purpura. Blood 1990;76:2321-2326.

  15. Foster CB, Zhu S, Erichsen HC, et al. Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot study. Br J Haematol 2001;113:596-599.

  16. Satoh T, Pandey JP, Okazaki Y, et al. Single nucleotide polymorphisms of the inflammatory cytokines genes in adults with chronic immune thrombocytopenic purpura. Haematol 2004;124:796-801.

  17. Shang B, Lo C, Shen L, et al. The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Blood 2011;117:4569-4579.

  18. Staci R, Sarpatwari A, Segal JB, et al. Effects of eradication of Helicobacter pylori infections in patients with immune thrombocytopenic purpura: a systemic review. Blood 2009;113:1231-1240.

  19. Ron-Guerrero CS, Barrera-Chairez E, Ron-Magaña AL, Razón-Gutiérrez JE. Trombocitopenia persistente parecida a púrpura trombocitopénica idiopática asociada al dengue hemorrágico: informe de tres casos. Rev Hematol Mex 2013;14:86-90.




2020     |     www.medigraphic.com